MTPC, Janssen Pharma Launch RA Treatment Simponi

September 26, 2011
Mitsubishi Tanabe Pharma Corporation (MTPC) and Janssen Pharmaceutical launched Simponi SC Injection 50 mg Syringe (golimumab), a recombinant human anti-human TNFα monoclonal antibody for the treatment of rheumatoid arthritis (RA), on September 16. The NHI price is ¥142,184 per 50...read more